Classification
- Anatomical main groupVVarious
- Therapeutic subgroupV03
- Pharmacological subgroupV03A
- Chemical subgroupV03AH
- Chemical substanceV03AH01Diazoxide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
New Zealand
PHARMAC (NZ funding schedule) · 5 registrations
- AnyInj 15 mg per ml, 20 ml ampoule
- e5 PharmaOral liq 50 mg per ml
- ProglicemCap 100 mg
- ProglicemCap 25 mg
United States
FDA · 5 registrations
- Diazoxide50MG/ML · suspension · E5 Pharma INC
- Proglycem50MG/ML · suspension · Teva Branded Pharm
- Diazoxide15MG/ML · injectable · Abraxis Pharm
- Hyperstat15MG/ML · injectable · Schering
Canada
At a glance
- ATC code
- V03AH01
- ATC group
- Various
- Registers
- 5
- Registrations
- 15
- With their own page
- 13
- Companies
- 8
All medicines with Diazoxide
Human medicines from every register that match Diazoxide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
18 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Diazoxide | United States | 50MG/ML | suspension | Marketed | E5 Pharma INC |
| Diazoxide | United States | 15MG/ML | injectable | Not marketed | Abraxis Pharm |
| Proglycem | United States | 50MG/ML | suspension | Marketed | Teva Branded Pharm |
| Hyperstat | United States | 15MG/ML | injectable | Not marketed | Schering |
| Proglycem | United States | 100MG, 50MG | capsule | Not marketed | Teva Branded Pharm |
| Proglicem, capsules 100 mg | Netherlands | Capsule, hard | Authorised | Merck Sharp & Dohme B.V. | |
| Proglycem | Canada | 100 MG | Capsule | Marketed | Merck Canada INC |
| Tensuril | Brazil | Authorised | Cristália Produtos Químicos Farmacêuticos Ltda. | ||
| Vykat XR | United States | 150MG, 25MG, 75MG | tablet, extended release | Marketed | Soleno Therap |
| Any | New Zealand | Inj 15 mg per ml, 20 ml ampoule | Funded | ||
| e5 Pharma | New Zealand | Oral liq 50 mg per ml | Funded | ||
| Proglicem | New Zealand | Cap 100 mg | Funded | ||
| Proglicem | New Zealand | Cap 25 mg | Funded | ||
| Proglycem | New Zealand | Oral liq 50 mg per ml | Funded | ||
| Hyperstat Inj 15MG/ML | Canada | 15 MG / ML | Liquid | Cancelled | Schering-Plough Canada INC |
| Proglycem Susp 50MG/ML | Canada | 50 MG / ML | Suspension | Cancelled | Schering-Plough Canada INC |
| Diazoxido | Brazil | Cancelled | Apsen Farmaceutica S/A | ||
| Viokat | European Union | Refused |